246 related articles for article (PubMed ID: 32552476)
1. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.
Chang Y; Liu Q; Zhou Z; Ding Y; Yang M; Xu W; Chen K; Zhang Q; Wang Z; Li H
Technol Cancer Res Treat; 2020; 19():1533033820934881. PubMed ID: 32552476
[TBL] [Abstract][Full Text] [Related]
2. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis.
Gu Y; Yang X; Liang H; Li D
BMC Gastroenterol; 2019 Dec; 19(1):231. PubMed ID: 31888534
[TBL] [Abstract][Full Text] [Related]
4. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.
Wang J; Li X
Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428
[TBL] [Abstract][Full Text] [Related]
5. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
Tsan YT; Lee CH; Wang JD; Chen PC
J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
[TBL] [Abstract][Full Text] [Related]
6. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.
Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293
[TBL] [Abstract][Full Text] [Related]
7. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma.
Wang Y; Wang W; Wang M; Shi J; Jia X; Dang S
Can J Gastroenterol Hepatol; 2022; 2022():5389044. PubMed ID: 35356132
[TBL] [Abstract][Full Text] [Related]
8. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
[TBL] [Abstract][Full Text] [Related]
9. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis of the effects of statins on the risk of chronic liver disease and hepatocellular carcinoma].
Wei J; Lvy JH; Sun XJ; Wu XR
Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):696-701. PubMed ID: 34371542
[No Abstract] [Full Text] [Related]
11. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.
Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H
Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717
[TBL] [Abstract][Full Text] [Related]
12. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
Cho Y; Kim MS; Nam CM; Kang ES
Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
[TBL] [Abstract][Full Text] [Related]
13. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
14. Statin use and risk of hepatocellular carcinoma in a U.S. population.
McGlynn KA; Divine GW; Sahasrabuddhe VV; Engel LS; VanSlooten A; Wells K; Yood MU; Alford SH
Cancer Epidemiol; 2014 Oct; 38(5):523-7. PubMed ID: 25113938
[TBL] [Abstract][Full Text] [Related]
15. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
[TBL] [Abstract][Full Text] [Related]
16. Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.
Siegel AB; El-Serag HB
Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):493-5. PubMed ID: 23984995
[No Abstract] [Full Text] [Related]
17. Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients: A Systematic Review and Meta-analysis.
Wong YJ; Qiu TY; Ng GK; Zheng Q; Teo EK
J Clin Gastroenterol; 2021 Aug; 55(7):615-623. PubMed ID: 33606427
[TBL] [Abstract][Full Text] [Related]
18. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis.
Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT
Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695
[TBL] [Abstract][Full Text] [Related]
19. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
El-Serag HB; Johnson ML; Hachem C; Morgana RO
Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
[TBL] [Abstract][Full Text] [Related]
20. Statin use and risk of liver cancer: an update meta-analysis.
Shi M; Zheng H; Nie B; Gong W; Cui X
BMJ Open; 2014 Sep; 4(9):e005399. PubMed ID: 25227628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
